A COMPARATIVE STUDY OF THE INHIBITORY ACTIVITY OF CLOFIBRATE AND RELATED ANALOGS ON LIPOPROTEIN LIPASE IN VITRO = ETUDE COMPARATIVE DE L'ACTIVITE INHIBITRICE DU CLOFIBRATE ET DES ANALOGUES APPARENTES SUR LA LIPOPROTEINE LIPASE IN VITRO1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 3; PP. 228-231; BIBL. 45REF.Serial Issue

CLOFIBRATE AND RELATED ANALOGS.WITIAK DT; NEWMAN HAI; FELLER DR et al.1977; MEDICIN. RES. SER.; U.S.A.; DA. 1977; VOL. 7; PP. (296P.); BIBL. 91 P. 1/2; ISBN 0824766814Serial Issue

COMPARISON OF HYPOCHOLESTEROLEMIC ACTIVITY FOR CYCLIC ANALOGS OF CLOFIBRATE IN NORMOLIPEMIC RATS.GOLBERG AF; MELLON WS; WITIAK DT et al.1977; ATHEROSCLEROSIS; NETHERL.; DA. 1977; VOL. 27; NO 1; PP. 15-25; BIBL. 1 P. 1/2Article

THE EFFECT OF CLOFIBRATE AND ANALOGS ON HUMAN POST-HEPARIN PLASMA LIPASES.GANESAN D; WHAYNE TF JR; WITIAK DT et al.1976; ARTERY; U.S.A.; DA. 1976; VOL. 2; NO 5; PP. 467-479; BIBL. 21 REF.Article

SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF CIS-3,4, -4A, 9A-TETRAHYDRO-14-PYRANO (3,4-B) BENZOFURAN-1-ONES. TRICYCLIC ANALOGUES RELATED TO THE ANTILEPIDEMIC DRUG CLOFIBRATEWITIAK DT; LOH W; FELLER DR et al.1979; J. MEDICIN. CHEM.; USA; DA. 1979; VOL. 22; NO 6; PP. 699-705; BIBL. 43 REF.Article

BINDING TO PLASMA LIPOPROTEINS OF CHLOROPHOXYISOBUTYRIC, TIBRIC AND NICOTINIC ACIDS AND THEIR ESTERS. ITS SIGNIFICANCE FOR THE MECHANISM OF LIPID LOWERING BY CLOFIBRATE AND RELATED DRUGS.BEAUMONT JL; DACHET C.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 25; NO 2-3; PP. 255-266; BIBL. 1 P. 1/2Article

SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF A CLOFIBRATE-RELATED TRICYCLIC SPIROLACTONE, 5-CHLORO-4',5'-DIHYDROSPIRO (BENZOFURAN-2(3H), 3' (2'H)-FURAN)-2'-ONEWITIAK DT; CAVESTRI RC; NEWMAN HAI et al.1978; J. MEDICIN. CHEM.; USA; DA. 1978; VOL. 21; NO 12; PP. 1198-1202; BIBL. 37 REF.Article

RECHERCHES SUR LES AGENTS HYPOLIPEMIANTS. I. SYNTHESE ET ACTIVITES HYPOLIPEMIANTES DES DERIVES DE L'ACIDE (CHLORO-4' PHENOXY)-2 ISOBUTYRIQUEMIYOSHI F; KURODA H; HIRAOKA K et al.1974; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JAP.; DA. 1974; VOL. 94; NO 3; PP. 387-396; ABS. ANGL.; BIBL. 16 REF.Article

COMPARISON OF THE EFFECTS OF THE HYPOLIPIDAEMIC AGENTS JCI 53072 AND CLOFIBRATE WITH THOSE OF PHENOBARBITONE ON LIVER SIZE, BLOOD FLOW AND DNA CONTENT IN THE RATBERMAN JS; HILEY CR; WILSON AC et al.1983; BRITISH JOURNAL OF PHARMACOLOGY; ISSN 0007-1188; GBR; DA. 1983; VOL. 78; NO 3; PP. 533-541; BIBL. 1 P.Article

OMEGA -ALCOYLAMINOETHYLESTER DE L'ACIDE PHENYLTHIOISOBUTYRIQUE. CHIMIE ET ACTIVITE PHARMACODYNAMIQUESIATRA PAPASTAICOUDI T; PAPADOPOULOU DAIPHOTI Z; DEMETRAKOPOULOS G et al.1979; CHIM. CHRON.; GRC; DA. 1979; VOL. 8; NO 1; PP. 3-8; ABS. ENG/GRE; BIBL. 11 REF.Article

POTENTIAL HYPOLIPIDEMIC AGENTS. XIX: SYNTHESIS AND LIPID-LOWERING PROPERTIES OF THIOPHENE DERIVATIVES RELATED TO CLOFIBRATEGRONOWITZ S; SVENSON R; BONDESSON G et al.1978; ACTA PHARM. SUECICA; SWE; DA. 1978; VOL. 15; NO 5; PP. 361-367; BIBL. 13 REF.Article

Analogues of clofibrate and clobuzarit containing fluorine in the side chainsHAYDOCK, D. B; MULHOLLAND, T. P. C; TELFORD, B et al.European journal of medicinal chemistry. 1984, Vol 19, Num 3, pp 205-214, issn 0223-5234Article

Synthesis and biological evaluation of new clofibrate analogues as potential PPARα agonistsPERRONE, Maria Grazia; SANTANDREA, Ernesto; DELL'UOMO, Natalina et al.European journal of medicinal chemistry. 2005, Vol 40, Num 2, pp 143-154, issn 0223-5234, 12 p.Article